#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Progressive familial intrahepatic cholestasis Oropharyngeal cancer recurrent Congenital hypotransferrinaemia Hypertriglyceridaemia Acute graft versus host disease in liver Germ cell cancer Thalassaemia Hairy cell leukaemia recurrent Ewing's sarcoma metastatic Peripheral T-cell lymphoma unspecified Thrombotic thrombocytopenic purpura Focal segmental glomerulosclerosis Palmar-plantar erythrodysaesthesia syndrome Malignant fibrous histiocytoma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Chondrosarcoma – Life with Disease Tuberous sclerosis complex – Diagnostics Haemophilia A without inhibitors – Treatment Progressive supranuclear palsy – Basic Information Gaucher’s disease type I – Life with Disease Primary hyperoxaluria – Diagnostics Carcinoid syndrome – Treatment Synovial sarcoma – Trials in Disease Osteosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Certolizumab Pegol Favezelimab Piracetam Thiamine Trospium Chloride Etanercept Fingolimod Hydrochloride L-Tyrosine Anhydrous Glucose Bp Bupivacaine Nelarabine Riluzole Magrolimab L-Lysine Acetate Azacitidine S-241656 Abacavir Sulfate Hhalpc Erythromycin Oleclumab More therapies…

    Learn about Your Condition

    Transient ischaemic attack Subdural haematoma Anal cancer metastatic Prostate cancer recurrent Primary amyloidosis Acarodermatitis Skin papilloma Colorectal adenoma Nasal sinus cancer Intervertebral disc protrusion Skin wrinkling Limb reduction defect Transplantation complication Cytomegalovirus infection Major depression More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psychological Phenomena

  • Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Propranolol for Preventing PTSD in Women After Sexual Violence

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Propranolol
    France

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Paroxetine
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    Poland

  • Study on the Effects of Intranasal Oxytocin on Social and Repetitive Behaviors in Youth with Autism Spectrum Disorder

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Oxytocin Synthetic
    • Sodium Chloride
    Norway

  • Study on the Effects of Rifaximin on Stress and Fear Responses in Healthy Men

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Rifaximin
    Belgium

  • Psilocybin Therapy for Hospitalized Patients with Treatment-Resistant Depression

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Belgium
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!